Publication | Open Access

Machine learning and natural language processing (NLP) approach to predict early progression to first-line treatment in real-world hormone receptor-positive (HR+)/HER2-negative advanced breast cancer patients

Natural Language ProcessingBreast OncologyOncologyMachine LearningEngineeringResponse PredictionBreast CancerMedical Language ProcessingMedicineEarly ProgressionHealth Informatics